MENTAL DISORDER IN CUSHING'S SYNDROME.
Glucocorticoid induced adrenal insufficiency.
Prete A, Bancos I.
BMJ. 2021 Jul 12;374:n1380. doi: 10.1136/bmj.n1380.
Complications of Cushing's syndrome: state of the art.
Pivonello R, Isidori AM, De Martino MC, Newell-Price J, Biller BM, Colao A.
Lancet Diabetes Endocrinol. 2016 Jul;4(7):611-29. doi: 10.1016/S2213-8587(16)00086-3. Epub 2016 May 10.
Systemic Absorption and Side Effects of Locally Injected Glucocorticoids.
Stout A, Friedly J, Standaert CJ.
PM R. 2019 Apr;11(4):409-419. doi: 10.1002/pmrj.12042. Epub 2019 Mar 29.
Stress and eating behaviors.
Yau YH, Potenza MN.
Minerva Endocrinol. 2013 Sep;38(3):255-67.
Psychiatric disorders associated with Cushing's syndrome.
Bratek A, Koźmin-Burzyńska A, Górniak E, Krysta K.
Psychiatr Danub. 2015 Sep;27 Suppl 1:S339-43.
Cushing's syndrome.
Howlett TA, Rees LH, Besser GM.
Clin Endocrinol Metab. 1985 Nov;14(4):911-45. doi: 10.1016/s0300-595x(85)80083-9.
Neuropsychological Functioning in Patients with Cushing's Disease and Cushing's Syndrome.
Siegel S, Kirstein CF, Grzywotz A, Hütter BO, Wrede KH, Kuhna V, Kreitschmann-Andermahr I.
Exp Clin Endocrinol Diabetes. 2021 Mar;129(3):194-202. doi: 10.1055/a-1247-4651. Epub 2020 Sep 29.
Patient reported outcomes and treatment satisfaction in patients with cushing syndrome.
Rakovec M, Zhu W, Khalafallah AM, Salvatori R, Hamrahian AH, Gallia GL, Ishii M, London NR Jr, Ramanathan M Jr, Rowan NR, Mukherjee D.
Endocrine. 2023 Jan;79(1):161-170. doi: 10.1007/s12020-022-03214-5. Epub 2022 Oct 13.
Psychiatric Symptoms in Patients with Cushing's Syndrome: Prevalence, Diagnosis and Management.
Santos A, Resmini E, Pascual JC, Crespo I, Webb SM.
Drugs. 2017 May;77(8):829-842. doi: 10.1007/s40265-017-0735-z.
[Pseudo-Cushing states].
Romanholi DJ, Salgado LR.
Arq Bras Endocrinol Metabol. 2007 Nov;51(8):1303-13. doi: 10.1590/s0004-27302007000800016.
